Evidence map›Paper›PMID 37313250›Full record

ArticleOman medical journal2023

Mucormycosis: An Epidemic Complicating the COVID-19 Pandemic.

Shalaka Khade, Aasma Nalwa, Meenakshi Rao, Divya Aggarwal, Vidhu Sharma, Ankita Chugh

Abstract readCase Reports
In one paragraph

Article in Oman medical journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shalaka KhadeDepartment of Pathology, All India Institute of Medical Sciences, Rajasthan, India.
Aasma NalwaDepartment of Pathology, All India Institute of Medical Sciences, Rajasthan, India.
Meenakshi RaoDepartment of Pathology, All India Institute of Medical Sciences, Rajasthan, India.
Divya AggarwalDepartment of Pathology, All India Institute of Medical Sciences, Rajasthan, India.
Vidhu SharmaDepartment of Pathology, All India Institute of Medical Sciences, Rajasthan, India.
Ankita ChughDepartment of Pathology, All India Institute of Medical Sciences, Rajasthan, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 is a relatively new disease whose complete pathogenesis and complications have not been elucidated. Apart from the morbidity and mortality caused by the virus itself, it is noted that patients affected with this virus have a higher susceptibility to bacterial and fungal co-infections. Mucormycosis is a rare and life-threatening fungal infection generally associated with uncontrolled diabetes mellitus and immunosuppression. It tends to rapid disease progression and poor prognosis if not diagnosed and managed promptly. There has been a sudden increase in the number of mucormycosis cases in patients with moderate to severe COVID-19 infection in the past few months. Herein, we present a series of 10 mucormycosis cases diagnosed over one week.

Indexed as

CoinfectionCOVID-19Mucormycosis

Identifiers

PMID37313250
PMCPMC10259156

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.